首页> 美国卫生研究院文献>other >Challenges to the recognition and assessment of Alzheimer’s disease in American Indians of the southwestern United States
【2h】

Challenges to the recognition and assessment of Alzheimer’s disease in American Indians of the southwestern United States

机译:美国西南部美洲印第安人对识别和评估阿尔茨海默氏病的挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Little is known about Alzheimer’s disease (AD) and related neurodegenerative diseases in American Indian (AI) populations. To provide appropriate health care to elder AIs, whose population is expected to increase dramatically during the next 50 years, it is imperative to attain a better understanding of the interaction of culture and disease in this underserved population. Raising awareness in the AI population regarding the nature of dementia as it compares to normal aging and the development of culturally appropriate instruments to detect and stage AD are essential for future health care efforts. Barriers restricting clinical service to this population include historical factors relating to access to health care, cultural beliefs regarding aging, demographic diversity of the population, competing epidemiologic risk factors, and lack of proper assessment tools for clinicians.
机译:对于美洲印第安人(AI)人群中的阿尔茨海默氏病(AD)和相关的神经退行性疾病知之甚少。为了给老年人的AI提供适当的医疗保健,这些AI的人口在未来50年预计将急剧增加,必须更好地了解这一服务不足的人群中文化与疾病之间的相互作用。与正常衰老相比,提高AI人群对痴呆症本质的认识,开发适合文化的检测和分期AD的手段对于未来的医疗保健工作至关重要。限制向该人群提供临床服务的障碍包括与获得医疗服务有关的历史因素,有关老龄化的文化观念,人群的人口多样性,流行病学风险因素相互竞争以及临床医生缺乏适当的评估工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号